PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Innovator IBD Breakout Opportunities ETF (BOUT)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

ETF Info

IssuerInnovator
Inception DateSep 13, 2018
RegionNorth America (U.S.)
CategoryAll Cap Equities
Index TrackedIBD Breakout Stocks Index
Asset ClassEquity

Asset Class Size

Multi-Cap

Asset Class Style

Blend

Expense Ratio

The Innovator IBD Breakout Opportunities ETF has a high expense ratio of 0.84%, indicating higher-than-average management fees.


Expense ratio chart for BOUT: current value at 0.84% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.84%

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Innovator IBD Breakout Opportunities ETF

Popular comparisons: BOUT vs. FFTY, BOUT vs. SPY, BOUT vs. QQQM, BOUT vs. SPMO, BOUT vs. VOO, BOUT vs. QQQ, BOUT vs. SCHG

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Innovator IBD Breakout Opportunities ETF, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-5.00%0.00%5.00%10.00%15.00%20.00%25.00%30.00%NovemberDecember2024FebruaryMarchApril
16.63%
19.37%
BOUT (Innovator IBD Breakout Opportunities ETF)
Benchmark (^GSPC)

S&P 500

Returns By Period

Innovator IBD Breakout Opportunities ETF had a return of 1.62% year-to-date (YTD) and 10.27% in the last 12 months.


PeriodReturnBenchmark
Year-To-Date1.62%6.30%
1 month-7.32%-3.13%
6 months16.63%19.37%
1 year10.27%22.56%
5 years (annualized)10.92%11.65%
10 years (annualized)N/A10.55%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2024-0.24%7.27%2.63%
2023-3.42%-4.37%6.50%8.40%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of BOUT is 42, suggesting that the investment has average results relative to the market in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.

The Risk-Adjusted Performance Rank of BOUT is 4242
Innovator IBD Breakout Opportunities ETF(BOUT)
The Sharpe Ratio Rank of BOUT is 4444Sharpe Ratio Rank
The Sortino Ratio Rank of BOUT is 4343Sortino Ratio Rank
The Omega Ratio Rank of BOUT is 4242Omega Ratio Rank
The Calmar Ratio Rank of BOUT is 4141Calmar Ratio Rank
The Martin Ratio Rank of BOUT is 3939Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Innovator IBD Breakout Opportunities ETF (BOUT) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


BOUT
Sharpe ratio
The chart of Sharpe ratio for BOUT, currently valued at 0.72, compared to the broader market-1.000.001.002.003.004.000.72
Sortino ratio
The chart of Sortino ratio for BOUT, currently valued at 1.10, compared to the broader market-2.000.002.004.006.008.001.10
Omega ratio
The chart of Omega ratio for BOUT, currently valued at 1.13, compared to the broader market1.001.502.001.13
Calmar ratio
The chart of Calmar ratio for BOUT, currently valued at 0.43, compared to the broader market0.002.004.006.008.0010.000.43
Martin ratio
The chart of Martin ratio for BOUT, currently valued at 1.87, compared to the broader market0.0010.0020.0030.0040.0050.001.87
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 1.92, compared to the broader market-1.000.001.002.003.004.001.92
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 2.78, compared to the broader market-2.000.002.004.006.008.002.78
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.33, compared to the broader market1.001.502.001.33
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.47, compared to the broader market0.002.004.006.008.0010.001.47
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 7.64, compared to the broader market0.0010.0020.0030.0040.0050.007.64

Sharpe Ratio

The current Innovator IBD Breakout Opportunities ETF Sharpe ratio is 0.72. A Sharpe ratio between 0 and 1.0 is considered sub-optimal.


Rolling 12-month Sharpe Ratio-0.500.000.501.001.502.002.503.00NovemberDecember2024FebruaryMarchApril
0.72
1.92
BOUT (Innovator IBD Breakout Opportunities ETF)
Benchmark (^GSPC)

Dividends

Dividend History

Innovator IBD Breakout Opportunities ETF granted a 1.30% dividend yield in the last twelve months. The annual payout for that period amounted to $0.44 per share.


PeriodTTM202320222021202020192018
Dividend$0.44$0.44$0.40$0.00$0.00$0.00$0.04

Dividend yield

1.30%1.32%1.35%0.00%0.00%0.00%0.22%

Monthly Dividends

The table displays the monthly dividend distributions for Innovator IBD Breakout Opportunities ETF. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDec
2024$0.00$0.00$0.00
2023$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.44
2022$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.40
2021$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2020$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2019$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2018$0.04

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-25.00%-20.00%-15.00%-10.00%-5.00%0.00%NovemberDecember2024FebruaryMarchApril
-11.05%
-3.50%
BOUT (Innovator IBD Breakout Opportunities ETF)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Innovator IBD Breakout Opportunities ETF. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Innovator IBD Breakout Opportunities ETF was 36.76%, occurring on Mar 20, 2020. Recovery took 95 trading sessions.

The current Innovator IBD Breakout Opportunities ETF drawdown is 11.05%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-36.76%Sep 17, 2018380Mar 20, 202095Aug 5, 2020475
-28.28%Dec 30, 2021187Sep 27, 2022
-14.69%Feb 17, 202169May 25, 2021111Nov 1, 2021180
-11.51%Aug 6, 202034Sep 23, 202013Oct 12, 202047
-8.18%Jan 20, 20216Jan 27, 20217Feb 5, 202113

Volatility

Volatility Chart

The current Innovator IBD Breakout Opportunities ETF volatility is 4.58%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


2.00%3.00%4.00%5.00%6.00%NovemberDecember2024FebruaryMarchApril
4.58%
3.58%
BOUT (Innovator IBD Breakout Opportunities ETF)
Benchmark (^GSPC)